0001611746
2026-01-01
2026-06-30
0001611746
sprc:NeuroTheraMember
sprc:SubsequentEventsMember
2026-08-13
0001611746
sprc:NeuroTheraMember
sprc:SubsequentEventsMember
2026-08-18
0001611746
sprc:ForecastMember
2026-08-18
0001611746
sprc:SubsequentEventsMember
2026-06-30
0001611746
sprc:ForecastMember
2026-08-18
2026-08-18
0001611746
2025-12-31
0001611746
sprc:OnlineSalesMember
2025-12-31
0001611746
sprc:DrugDevelopmentMember
2025-12-31
0001611746
2026-06-30
0001611746
sprc:QuantumTechnologyMember
2026-06-30
0001611746
sprc:OnlineSalesMember
2026-06-30
0001611746
sprc:DrugDevelopmentMember
2026-06-30
0001611746
ifrs-full:OperatingSegmentsMember
2025-01-01
2025-06-30
0001611746
sprc:OnlineSalesMember
ifrs-full:OperatingSegmentsMember
2025-01-01
2025-06-30
0001611746
sprc:DrugDevelopmentMember
ifrs-full:OperatingSegmentsMember
2025-01-01
2025-06-30
0001611746
ifrs-full:OperatingSegmentsMember
2026-01-01
2026-06-30
0001611746
sprc:QuantumTechnologyMember
ifrs-full:OperatingSegmentsMember
2026-01-01
2026-06-30
0001611746
sprc:OnlineSalesMember
ifrs-full:OperatingSegmentsMember
2026-01-01
2026-06-30
0001611746
sprc:DrugDevelopmentMember
ifrs-full:OperatingSegmentsMember
2026-01-01
2026-06-30
0001611746
2025-01-01
2025-06-30
0001611746
sprc:RegulatoryExpensesMember
2025-01-01
2025-06-30
0001611746
sprc:RegulatoryExpensesMember
2026-01-01
2026-06-30
0001611746
sprc:InvestorRelationsAndBusinessExpensesMember
2025-01-01
2025-06-30
0001611746
sprc:InvestorRelationsAndBusinessExpensesMember
2026-01-01
2026-06-30
0001611746
sprc:OfficeMaintenanceRentAndOtherExpensesMember
2025-01-01
2025-06-30
0001611746
sprc:OfficeMaintenanceRentAndOtherExpensesMember
2026-01-01
2026-06-30
0001611746
sprc:BusinessDevelopmentExpensesMember
2025-01-01
2025-06-30
0001611746
sprc:BusinessDevelopmentExpensesMember
2026-01-01
2026-06-30
0001611746
sprc:ProfessionalAndDirectorsFeesMember
2025-01-01
2025-06-30
0001611746
sprc:ProfessionalAndDirectorsFeesMember
2026-01-01
2026-06-30
0001611746
sprc:ShareBasedPaymentMember
2025-01-01
2025-06-30
0001611746
sprc:ShareBasedPaymentMember
2026-01-01
2026-06-30
0001611746
sprc:WagesAndRelatedExpensesMember
2025-01-01
2025-06-30
0001611746
sprc:WagesAndRelatedExpensesMember
2026-01-01
2026-06-30
0001611746
sprc:ChemistryAndFormulationsMember
2025-01-01
2025-06-30
0001611746
sprc:ChemistryAndFormulationsMember
2026-01-01
2026-06-30
0001611746
sprc:ResearchAndPreclinicalStudiesMember
2025-01-01
2025-06-30
0001611746
sprc:ResearchAndPreclinicalStudiesMember
2026-01-01
2026-06-30
0001611746
sprc:RegulatoryProfessionalAndOtherExpensesMember
2025-01-01
2025-06-30
0001611746
sprc:RegulatoryProfessionalAndOtherExpensesMember
2026-01-01
2026-06-30
0001611746
sprc:ClinicalStudiesMember
2025-01-01
2025-06-30
0001611746
sprc:ClinicalStudiesMember
2026-01-01
2026-06-30
0001611746
sprc:CliniQTransactionMember
2026-06-30
0001611746
sprc:PrefundedWarrantsMember
ifrs-full:OrdinarySharesMember
sprc:XyloMember
2026-01-26
0001611746
sprc:PrefundedWarrantsMember
sprc:XyloMember
2026-01-26
2026-01-26
0001611746
ifrs-full:OrdinarySharesMember
sprc:January2026FinancingRoundMember
2026-01-13
2026-01-13
0001611746
sprc:SecuritiesPurchaseAgreementsMember
2026-01-13
0001611746
sprc:SEPAMember
2026-01-14
2026-01-14
0001611746
sprc:January2024StandbyEquityPurchaseAgreementMember
2024-01-21
0001611746
sprc:SEPAMember
sprc:January2024StandbyEquityPurchaseAgreementMember
2025-01-01
2025-12-31
0001611746
sprc:January2024StandbyEquityPurchaseAgreementMember
2025-01-01
2025-12-31
0001611746
sprc:January2024StandbyEquityPurchaseAgreementMember
2024-01-21
2024-01-21
0001611746
sprc:AdditionalIssuanceOfOrdinarySharesMember
2026-06-23
0001611746
sprc:AdditionalIssuanceOfOrdinarySharesMember
2026-04-30
0001611746
ifrs-full:OrdinarySharesMember
2026-01-07
2026-01-07
0001611746
ifrs-full:OrdinarySharesMember
2026-01-07
0001611746
2025-01-01
2025-12-31
0001611746
sprc:May2022Warrants1Member
2025-01-01
2025-12-31
0001611746
sprc:MarchTwoThousandAndTwentyOneSeriesBWarrantsMember
2025-01-01
2025-12-31
0001611746
sprc:MarchTwoThousandAndTwentyOneSeriesAWarrantsMember
2025-01-01
2025-12-31
0001611746
sprc:February2026WarrantsMember
2026-01-01
2026-06-30
0001611746
sprc:MayTwoThousandAndTwentyTwoWarrantsMember
2026-01-01
2026-06-30
0001611746
sprc:PolyrizonSeriesAWarrantsMember
2025-12-31
0001611746
ifrs-full:Level1OfFairValueHierarchyMember
sprc:PolyrizonSeriesAWarrantsMember
2025-12-31
0001611746
sprc:NexeraSharesMember
2025-12-31
0001611746
ifrs-full:Level1OfFairValueHierarchyMember
sprc:NexeraSharesMember
2025-12-31
0001611746
sprc:AutoMaxSharesMember
2025-12-31
0001611746
ifrs-full:Level1OfFairValueHierarchyMember
sprc:AutoMaxSharesMember
2025-12-31
0001611746
sprc:NexentisSharesMember
2025-12-31
0001611746
ifrs-full:Level1OfFairValueHierarchyMember
sprc:NexentisSharesMember
2025-12-31
0001611746
ifrs-full:Level3OfFairValueHierarchyMember
2026-06-30
0001611746
ifrs-full:Level2OfFairValueHierarchyMember
2026-06-30
0001611746
sprc:PolyrizonSeriesAWarrantsMember
2026-06-30
0001611746
ifrs-full:Level1OfFairValueHierarchyMember
sprc:PolyrizonSeriesAWarrantsMember
2026-06-30
0001611746
sprc:NexeraSharesMember
2026-06-30
0001611746
ifrs-full:Level1OfFairValueHierarchyMember
sprc:NexeraSharesMember
2026-06-30
0001611746
sprc:AutoMaxSharesMember
2026-06-30
0001611746
ifrs-full:Level1OfFairValueHierarchyMember
sprc:AutoMaxSharesMember
2026-06-30
0001611746
sprc:NexentisSharesMember
2026-06-30
0001611746
ifrs-full:Level1OfFairValueHierarchyMember
sprc:NexentisSharesMember
2026-06-30
0001611746
2025-06-30
0001611746
srt:ScenarioForecastMember
2029-02-12
2029-02-12
0001611746
ifrs-full:WarrantsMember
srt:ScenarioForecastMember
2029-02-12
0001611746
ifrs-full:WarrantsMember
2026-06-30
0001611746
ifrs-full:TopOfRangeMember
2026-06-30
0001611746
ifrs-full:BottomOfRangeMember
2026-06-30
0001611746
2026-02-12
0001611746
2026-02-12
2026-02-12
0001611746
sprc:PolyrizonMember
2025-04-01
0001611746
sprc:PolyrizonMember
sprc:SecuritiesPurchaseAgreementMember
2025-04-01
0001611746
sprc:ThirdPartyMember
sprc:LicenseeCommonWarrantsMember
2024-12-30
2024-12-30
0001611746
sprc:ThirdPartyMember
sprc:LicenseeCommonWarrantsMember
2024-12-30
0001611746
sprc:LicenseAgreementMember
2024-08-13
2024-08-13
0001611746
sprc:CooperationAgreementMember
2026-01-01
2026-06-30
0001611746
sprc:NexeraTechnologiesLtdMember
2026-01-01
2026-06-30
0001611746
sprc:NexeraTechnologiesLtdMember
2025-01-01
2025-06-30
0001611746
ifrs-full:OrdinarySharesMember
sprc:NexeraTechnologiesLtdMember
2026-01-01
2026-06-30
0001611746
sprc:NexeraTechnologiesLtdMember
2023-12-31
0001611746
ifrs-full:OtherRelatedPartiesMember
2025-12-31
0001611746
ifrs-full:OtherRelatedPartiesMember
2026-06-30
0001611746
ifrs-full:KeyManagementPersonnelOfEntityOrParentMember
2025-12-31
0001611746
ifrs-full:KeyManagementPersonnelOfEntityOrParentMember
2026-06-30
0001611746
2025-11-20
0001611746
2025-11-20
2025-11-20
0001611746
2024-04-10
2024-04-10
0001611746
sprc:MergerAgreementMember
2024-04-10
2024-04-10
0001611746
2025-02-25
0001611746
2025-02-27
2025-02-27
0001611746
2025-02-27
0001611746
2024-09-05
0001611746
sprc:BridgeLoanAgreementMember
2024-06-09
0001611746
2024-06-09
0001611746
sprc:BridgeLoanAgreementMember
ifrs-full:TopOfRangeMember
2024-01-16
0001611746
sprc:BridgeLoanAgreementMember
ifrs-full:BottomOfRangeMember
2024-01-16
0001611746
sprc:BridgeLoanAgreementMember
2024-01-16
0001611746
sprc:AutoMaxSharesMember
2025-01-01
2025-06-30
0001611746
sprc:AutoMaxSharesMember
2026-01-01
2026-06-30
0001611746
sprc:AutoMaxSharesMember
2023-06-25
2023-06-25
0001611746
sprc:AutoMaxSharesMember
2023-06-25
0001611746
2023-06-25
0001611746
2023-06-25
2023-06-25
0001611746
sprc:ClearmindMember
2025-01-01
2025-06-30
0001611746
sprc:ClearmindMember
2026-01-01
2026-06-30
0001611746
sprc:InitialPublicOfferingMember
2025-12-31
0001611746
ifrs-full:BottomOfRangeMember
2025-01-01
2025-12-31
0001611746
ifrs-full:OrdinarySharesMember
2025-12-31
0001611746
2022-11-17
2022-11-17
0001611746
sprc:InitialPublicOfferingMember
2022-11-17
0001611746
sprc:InitialPublicOfferingMember
2022-11-17
2022-11-17
0001611746
sprc:PolyrizonMember
2025-12-31
0001611746
sprc:PolyrizonMember
2025-06-30
0001611746
sprc:PolyrizonMember
2026-06-30
0001611746
sprc:NexeraMember
2025-12-31
0001611746
sprc:NexeraMember
2025-06-30
0001611746
sprc:NexeraMember
2026-06-30
0001611746
sprc:AutoMaxMember
2025-12-31
0001611746
sprc:AutoMaxMember
2025-06-30
0001611746
sprc:AutoMaxMember
2026-06-30
0001611746
sprc:ClearmindMember
2025-06-30
0001611746
sprc:NexentisMember
2025-12-31
0001611746
sprc:NexentisMember
2026-06-30
0001611746
sprc:NetBalanceMember
2025-12-31
0001611746
sprc:NetBalanceMember
sprc:BrandMember
2025-12-31
0001611746
sprc:NetBalanceMember
2026-06-30
0001611746
sprc:NetBalanceMember
sprc:ExcessPurchasePriceMember
2026-06-30
0001611746
sprc:NetBalanceMember
sprc:IPPortfolioMember
2026-06-30
0001611746
sprc:NetBalanceMember
sprc:BrandMember
2026-06-30
0001611746
sprc:AccumulatedAmortizationAndImpairmentChargesMember
2026-06-30
0001611746
sprc:BrandMember
sprc:AccumulatedAmortizationAndImpairmentChargesMember
2026-06-30
0001611746
sprc:AccumulatedAmortizationAndImpairmentChargesMember
2026-01-01
2026-06-30
0001611746
sprc:BrandMember
sprc:AccumulatedAmortizationAndImpairmentChargesMember
2026-01-01
2026-06-30
0001611746
sprc:AccumulatedAmortizationAndImpairmentChargesMember
2025-12-31
0001611746
sprc:BrandMember
sprc:AccumulatedAmortizationAndImpairmentChargesMember
2025-12-31
0001611746
ifrs-full:GrossCarryingAmountMember
2026-06-30
0001611746
ifrs-full:GrossCarryingAmountMember
sprc:ExcessPurchasePriceMember
2026-06-30
0001611746
ifrs-full:GrossCarryingAmountMember
sprc:IPPortfolioMember
2026-06-30
0001611746
ifrs-full:GrossCarryingAmountMember
sprc:BrandMember
2026-06-30
0001611746
ifrs-full:GrossCarryingAmountMember
2026-01-01
2026-06-30
0001611746
ifrs-full:GrossCarryingAmountMember
sprc:ExcessPurchasePriceMember
2026-01-01
2026-06-30
0001611746
ifrs-full:GrossCarryingAmountMember
sprc:IPPortfolioMember
2026-01-01
2026-06-30
0001611746
ifrs-full:GrossCarryingAmountMember
2025-12-31
0001611746
ifrs-full:GrossCarryingAmountMember
sprc:BrandMember
2025-12-31
0001611746
ifrs-full:TechnologybasedIntangibleAssetsMember
2026-01-01
2026-06-30
0001611746
sprc:CliniQMember
2026-06-30
0001611746
sprc:CliniQMember
ifrs-full:BottomOfRangeMember
2026-01-01
2026-06-30
0001611746
sprc:CliniQMember
ifrs-full:TopOfRangeMember
2026-01-01
2026-06-30
0001611746
ifrs-full:OrdinarySharesMember
sprc:CliniQMember
2026-06-30
0001611746
sprc:NeuroTheraMember
2026-06-30
0001611746
ifrs-full:OrdinarySharesMember
sprc:NeuroTheraMember
2026-06-30
0001611746
sprc:CliniQuantumLtdMember
2026-06-03
2026-06-03
0001611746
sprc:MizaMember
2025-10-09
2025-10-09
0001611746
ifrs-full:OrdinarySharesMember
2026-01-01
2026-06-30
0001611746
ifrs-full:OrdinarySharesMember
sprc:SubsequentEventsMember
2026-01-01
2026-06-30
0001611746
2024-12-31
0001611746
ifrs-full:NoncontrollingInterestsMember
2025-06-30
0001611746
ifrs-full:ParentMember
2025-06-30
0001611746
ifrs-full:RetainedEarningsMember
2025-06-30
0001611746
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
2025-06-30
0001611746
ifrs-full:OtherEquityInterestMember
2025-06-30
0001611746
ifrs-full:WarrantsMember
2025-06-30
0001611746
ifrs-full:ReserveOfSharebasedPaymentsMember
2025-06-30
0001611746
ifrs-full:SharePremiumMember
2025-06-30
0001611746
ifrs-full:ParentMember
2025-01-01
2025-06-30
0001611746
ifrs-full:ReserveOfSharebasedPaymentsMember
2025-01-01
2025-06-30
0001611746
ifrs-full:SharePremiumMember
2025-01-01
2025-06-30
0001611746
ifrs-full:NoncontrollingInterestsMember
2025-01-01
2025-06-30
0001611746
ifrs-full:RetainedEarningsMember
2025-01-01
2025-06-30
0001611746
ifrs-full:NoncontrollingInterestsMember
2024-12-31
0001611746
ifrs-full:ParentMember
2024-12-31
0001611746
ifrs-full:RetainedEarningsMember
2024-12-31
0001611746
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
2024-12-31
0001611746
ifrs-full:OtherEquityInterestMember
2024-12-31
0001611746
ifrs-full:WarrantsMember
2024-12-31
0001611746
ifrs-full:ReserveOfSharebasedPaymentsMember
2024-12-31
0001611746
ifrs-full:SharePremiumMember
2024-12-31
0001611746
ifrs-full:NoncontrollingInterestsMember
2026-06-30
0001611746
ifrs-full:ParentMember
2026-06-30
0001611746
ifrs-full:RetainedEarningsMember
2026-06-30
0001611746
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
2026-06-30
0001611746
ifrs-full:OtherEquityInterestMember
2026-06-30
0001611746
ifrs-full:WarrantsMember
2026-06-30
0001611746
ifrs-full:ReserveOfSharebasedPaymentsMember
2026-06-30
0001611746
ifrs-full:SharePremiumMember
2026-06-30
0001611746
ifrs-full:ParentMember
2026-01-01
2026-06-30
0001611746
ifrs-full:ReserveOfSharebasedPaymentsMember
2026-01-01
2026-06-30
0001611746
ifrs-full:NoncontrollingInterestsMember
2026-01-01
2026-06-30
0001611746
ifrs-full:OtherEquityInterestMember
2026-01-01
2026-06-30
0001611746
ifrs-full:WarrantsMember
2026-01-01
2026-06-30
0001611746
ifrs-full:SharePremiumMember
2026-01-01
2026-06-30
0001611746
ifrs-full:RetainedEarningsMember
2026-01-01
2026-06-30
0001611746
ifrs-full:NoncontrollingInterestsMember
2025-12-31
0001611746
ifrs-full:ParentMember
2025-12-31
0001611746
ifrs-full:RetainedEarningsMember
2025-12-31
0001611746
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
2025-12-31
0001611746
ifrs-full:OtherEquityInterestMember
2025-12-31
0001611746
ifrs-full:WarrantsMember
2025-12-31
0001611746
ifrs-full:ReserveOfSharebasedPaymentsMember
2025-12-31
0001611746
ifrs-full:SharePremiumMember
2025-12-31
0001611746
sprc:IPPortfolioMember
sprc:AccumulatedAmortizationAndImpairmentChargesMember
2026-01-01
2026-06-30
0001611746
sprc:ExcessPurchasePriceMember
sprc:AccumulatedAmortizationAndImpairmentChargesMember
2026-01-01
2026-06-30
0001611746
sprc:IPPortfolioMember
sprc:AccumulatedAmortizationAndImpairmentChargesMember
2026-06-30
0001611746
sprc:ExcessPurchasePriceMember
sprc:AccumulatedAmortizationAndImpairmentChargesMember
2026-06-30
0001611746
sprc:NetBalanceMember
sprc:IPPortfolioMember
2025-12-31
0001611746
sprc:NetBalanceMember
sprc:ExcessPurchasePriceMember
2025-12-31
0001611746
sprc:NexentisMember
2025-06-30
0001611746
sprc:ClearmindMember
2026-06-30
0001611746
sprc:ClearmindMember
2025-12-31
0001611746
sprc:DeemedIssuanceListingExpensesMember
2026-01-01
2026-06-30
0001611746
sprc:DeemedIssuanceListingExpensesMember
2025-01-01
2025-06-30
0001611746
ifrs-full:Level2OfFairValueHierarchyMember
sprc:NexentisSharesMember
2026-06-30
0001611746
ifrs-full:Level3OfFairValueHierarchyMember
sprc:NexentisSharesMember
2026-06-30
0001611746
ifrs-full:Level1OfFairValueHierarchyMember
sprc:ClearmindSharesMember
2026-06-30
0001611746
ifrs-full:Level2OfFairValueHierarchyMember
sprc:ClearmindSharesMember
2026-06-30
0001611746
ifrs-full:Level3OfFairValueHierarchyMember
sprc:ClearmindSharesMember
2026-06-30
0001611746
ifrs-full:Level2OfFairValueHierarchyMember
sprc:AutoMaxSharesMember
2026-06-30
0001611746
ifrs-full:Level3OfFairValueHierarchyMember
sprc:AutoMaxSharesMember
2026-06-30
0001611746
ifrs-full:Level2OfFairValueHierarchyMember
sprc:NexeraSharesMember
2026-06-30
0001611746
ifrs-full:Level3OfFairValueHierarchyMember
sprc:NexeraSharesMember
2026-06-30
0001611746
ifrs-full:Level2OfFairValueHierarchyMember
sprc:PolyrizonSeriesAWarrantsMember
2026-06-30
0001611746
ifrs-full:Level3OfFairValueHierarchyMember
sprc:PolyrizonSeriesAWarrantsMember
2026-06-30
0001611746
ifrs-full:Level2OfFairValueHierarchyMember
sprc:NexentisSharesMember
2025-12-31
0001611746
ifrs-full:Level3OfFairValueHierarchyMember
sprc:NexentisSharesMember
2025-12-31
0001611746
ifrs-full:Level1OfFairValueHierarchyMember
sprc:ClearmindSharesMember
2025-12-31
0001611746
ifrs-full:Level2OfFairValueHierarchyMember
sprc:ClearmindSharesMember
2025-12-31
0001611746
ifrs-full:Level3OfFairValueHierarchyMember
sprc:ClearmindSharesMember
2025-12-31
0001611746
ifrs-full:Level2OfFairValueHierarchyMember
sprc:AutoMaxSharesMember
2025-12-31
0001611746
ifrs-full:Level3OfFairValueHierarchyMember
sprc:AutoMaxSharesMember
2025-12-31
0001611746
ifrs-full:Level2OfFairValueHierarchyMember
sprc:NexeraSharesMember
2025-12-31
0001611746
ifrs-full:Level3OfFairValueHierarchyMember
sprc:NexeraSharesMember
2025-12-31
0001611746
ifrs-full:Level2OfFairValueHierarchyMember
sprc:PolyrizonSeriesAWarrantsMember
2025-12-31
0001611746
ifrs-full:Level3OfFairValueHierarchyMember
sprc:PolyrizonSeriesAWarrantsMember
2025-12-31
0001611746
sprc:ClearmindSharesMember
2026-06-30
0001611746
sprc:ClearmindSharesMember
2025-12-31
0001611746
ifrs-full:Level1OfFairValueHierarchyMember
2026-06-30
0001611746
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
2026-01-01
2026-06-30
0001611746
ifrs-full:GrossCarryingAmountMember
sprc:IPPortfolioMember
2025-12-31
0001611746
ifrs-full:GrossCarryingAmountMember
sprc:ExcessPurchasePriceMember
2025-12-31
0001611746
ifrs-full:GrossCarryingAmountMember
sprc:BrandMember
2026-01-01
2026-06-30
0001611746
sprc:IPPortfolioMember
sprc:AccumulatedAmortizationAndImpairmentChargesMember
2025-12-31
0001611746
sprc:ExcessPurchasePriceMember
sprc:AccumulatedAmortizationAndImpairmentChargesMember
2025-12-31
0001611746
ifrs-full:WarrantsMember
2025-01-01
2025-06-30
0001611746
ifrs-full:OtherEquityInterestMember
2025-01-01
2025-06-30
0001611746
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
2025-01-01
2025-06-30
iso4217:USD
iso4217:CAD
xbrli:pure
iso4217:USD
xbrli:shares
iso4217:CAD
xbrli:shares
xbrli:shares
iso4217:ILS
xbrli:shares
iso4217:ILS
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of September 2026 (Report No. 3)
Commission file number: 001-38041
SCISPARC LTD.
(Translation of registrant’s name into English)
20 Raul Wallenberg Street, Tower A,
Tel Aviv 6971916 Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
CONTENTS
This Report of Foreign Private Issuer on Form 6-K consists of: (i) SciSparc Ltd.’s (the “Registrant”) Unaudited Consolidated Interim Financial Statements as of June 30, 2026, which is attached hereto as Exhibit 99.1; and (ii) the Registrant’s Management’s Discussion and Analysis of Financial Condition and Results of Operations for the six months ended June 30, 2026, which is attached hereto as Exhibit 99.2.
This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Registrant’s registration statements on Form F-3 (File Nos. 333-286099, 333-275305, 333-269839, 333-266047, 333-248670, 333-255408, 333-293167 and 333-293533) and on Form S-8 (File Nos. 333-278437, 333-225773, 333-286791 and 333-292952) filed with the Securities and Exchange Commission to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | SciSparc Ltd. |
| | | |
| Date: September 30, 2026 | By: | /s/ Oz Adler |
| | Name: | Oz Adler |
| | Title: | Chief Executive Officer and Chief Financial Officer |